<h4>Understanding Cervical Cancer and HPV</h4><p><strong>Cervical cancer</strong> is a significant global health concern. A staggering <strong>99%</strong> of almost all cervical cancer cases are directly linked to infection with high-risk <strong>Human Papillomavirus (HPV)</strong>. This virus is extremely common and is primarily transmitted through sexual contact.</p><div class='key-point-box'><p><strong>Key Concept:</strong> The strong causal link between <strong>HPV infection</strong> and <strong>cervical cancer</strong> highlights the importance of targeted preventive measures.</p></div><h4>Prevention and Treatment of Cervical Cancer</h4><p>Most cases of <strong>cervical cancer</strong> are preventable through effective primary and secondary strategies. <strong>Primary prevention</strong> involves <strong>HPV vaccination</strong>, which protects against the most common high-risk strains of the virus. <strong>Secondary prevention</strong> focuses on regular <strong>screening</strong> to detect and treat precancerous lesions before they develop into invasive cancer.</p><p>When diagnosed early and managed effectively, <strong>cervical cancer</strong> is considered one of the most successfully treatable forms of cancer. Early detection significantly improves patient outcomes and survival rates.</p><h4>Cervical Cancer Burden in India</h4><p><strong>India</strong> carries a substantial portion of the global burden of <strong>cervical cancer</strong>. The country accounts for approximately <strong>one-fifth</strong> of worldwide cases. Annually, India records about <strong>1.25 lakh new cases</strong> and tragically, around <strong>75,000 deaths</strong> due to cervical cancer.</p><div class='info-box'><p><strong>India's Cervical Cancer Statistics (Annual):</strong></p><ul><li>New Cases: <strong>~1.25 lakh</strong></li><li>Deaths: <strong>~75,000</strong></li><li>Global Burden Share: <strong>~20%</strong></li></ul></div><h4>High-Risk HPV Strains</h4><p>Persistent infections with specific high-risk <strong>HPV strains</strong> are responsible for nearly <strong>85%</strong> of all <strong>cervical cancers</strong>. Scientists have identified at least <strong>14 HPV types</strong> that are classified as <strong>oncogenic</strong>, meaning they have the potential to cause cancer.</p><ul><li>Among these, <strong>HPV types 16</strong> and <strong>18</strong> are considered the most oncogenic.</li><li>These two types alone are responsible for approximately <strong>70%</strong> of all cervical cancer cases globally.</li></ul><div class='info-box'><p><strong>Key Oncogenic HPV Types:</strong> <strong>HPV 16</strong> and <strong>HPV 18</strong> are implicated in <strong>70%</strong> of global cervical cancer cases.</p></div><h4>Ovarian Cancer Awareness Month</h4><p>While the primary focus of prevention and awareness often highlights cervical cancer due to its strong link with HPV, other gynecological cancers also require significant attention. The <strong>American Association for Cancer Research (AACR)</strong>, the world’s oldest and largest professional organization dedicated to cancer research, has designated <strong>September</strong> as <strong>Ovarian Cancer Awareness Month</strong>.</p><div class='exam-tip-box'><p><strong>UPSC Insight:</strong> Be aware of the distinction between <strong>Cervical Cancer</strong> (linked to HPV, preventable by vaccine) and <strong>Ovarian Cancer</strong> (different etiology, often detected late). While the source details cervical cancer, the awareness month is for ovarian cancer. This distinction is crucial for comprehensive understanding in Mains answers.</p></div>